[ad_1]
Up to 50 million doses are expected to be delivered worldwide by 2020.
The vaccine, jointly developed by Pfizer and BioNTech, has been shown to be 90% effective in preventing COVID-19 infections in the third phase of its clinical trials, AFP reported. Protection in patients was achieved seven days after the second of the two doses and 28 days after the first, according to preliminary findings.
Oxford COVID-19 Vaccine Results Expected in December
“The first set of results from our Phase 3 COVID-19 vaccine trial provides initial evidence of its ability to prevent COVID-19,” said Albert Burla, President and CEO of Pfizer.
“We are a significant step closer to giving people around the world the much-needed breakthrough to end this global health crisis. We are reaching this stage in our vaccine development program at a time when the world is increasingly He needs it, “Burla added.
According to estimates, the companies said they expect to deliver up to 50 million doses of vaccines worldwide in 2020 and up to 1.3 billion doses in 2021.
EC: There will not be enough vaccines for Europeans before 2022
In most of the world, the incidence of COVID-19 is increasing, reaching record levels. Intensive care units are filling up. The death toll is also increasing.
Donald Trump and Joe Biden commented on the new discovery. Trump wrote on Twitter that “the news is excellent.”
According to Biden, “the vaccine inspires hope, but there is a long battle ahead”
“I congratulate the brilliant men and women who helped make this breakthrough. They gave us hope,” the president-elect said in a statement. He added that we are still fighting the virus and it is important to wear masks.
READ ALL ABOUT CORONAVIRUS IN OUR COUNTRY AND ALL OVER THE WORLD HERE
To be the first to know the news from Bulgaria and the world, download the new NOVA app – for Android HERE or iOS (Apple) HERE.
Source: BGNES
[ad_2]
